Bruno Gran Selected Research

Bruno Gran Research Topics

Disease

31	Multiple Sclerosis 01/2022 - 11/2003
31	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2018 - 12/2002
11	Demyelinating Diseases (Demyelinating Disease) 01/2021 - 12/2002
10	Inflammation (Inflammations) 01/2016 - 03/2004
6	Infections 01/2020 - 12/2007
5	Epstein-Barr Virus Infections 01/2022 - 12/2016
5	Autoimmune Diseases (Autoimmune Disease) 11/2015 - 11/2003
3	Neuroinflammatory Diseases 01/2019 - 08/2010
1	Pain (Aches) 10/2022
1	Necrosis 10/2022
1	Neurogenic Inflammation 10/2022
1	Enterovirus Infections 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Dental Calculus 01/2019
1	HIV Infections (HIV Infection) 01/2018
1	Acute-Phase Reaction 01/2018
1	Gliosis 01/2017
1	Acute Disease 01/2017
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2016
1	Encephalomyelitis (Myeloencephalitis) 01/2016
1	Lower Urinary Tract Symptoms 01/2014
1	Pseudotumor Cerebri (Idiopathic Intracranial Hypertension) 01/2013
1	Immune System Diseases (Immune Disorders) 03/2012
1	Disease Progression 03/2011
1	Relapsing-Remitting Multiple Sclerosis 03/2011
1	Starvation 11/2010

Drug/Important Bio-Agent (IBA)

8	Interleukin-12 (IL 12)IBA 01/2021 - 12/2002
8	Interleukin-23 (Interleukin 23)IBA 02/2008 - 02/2003
7	CytokinesIBA 09/2015 - 01/2004
5	Myelin-Oligodendrocyte GlycoproteinIBA 01/2017 - 03/2004
4	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018 - 06/2009
3	AutoantigensIBA 12/2016 - 03/2006
3	Peptides (Polypeptides)IBA 12/2016 - 03/2012
3	Interleukin-10 (Interleukin 10)IBA 01/2016 - 12/2007
3	Therapeutic UsesIBA 11/2015 - 12/2005
3	Interleukin-17 (Interleukin 17)IBA 01/2013 - 12/2007
3	Interleukin-27 (Interleukin 27)IBA 12/2007 - 05/2005
2	NeuropeptidesIBA 10/2022 - 09/2015
2	Substance PIBA 10/2022 - 09/2015
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 07/2020 - 10/2014
2	Interleukin-2 (IL2)IBA 07/2020 - 01/2013
2	Immunoglobulin G (IgG)IBA 01/2020 - 03/2004
2	Toll-Like Receptor 2IBA 01/2018 - 01/2017
2	EpitopesIBA 01/2017 - 01/2016
2	SteroidsIBA 01/2014 - 07/2011
2	InterleukinsIBA 01/2013 - 12/2007
2	InterferonsIBA 07/2011 - 03/2011
2	AntibodiesIBA 01/2010 - 03/2004
2	Interleukin-23 Subunit p19IBA 02/2007 - 11/2003
2	Interleukin-12 Receptors (Interleukin 12 Receptor)IBA 11/2003 - 02/2003
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2022
1	VaccinesIBA 01/2022
1	Cladribine FDA LinkGeneric 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2020
1	EBV-encoded nuclear antigen 1IBA 01/2020
1	SmokeIBA 01/2019
1	Biological ProductsIBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	C-Reactive ProteinIBA 01/2018
1	Viral ProteinsIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2017
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2016
1	Pattern Recognition ReceptorsIBA 01/2016
1	Immunodominant EpitopesIBA 01/2016
1	Cathepsin GIBA 01/2016
1	Serine Proteases (Serine Protease)IBA 01/2016
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2016
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 11/2015
1	baicalinIBA 11/2015
1	Interferon Regulatory FactorsIBA 07/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2014
1	Interleukin-4 (Interleukin 4)IBA 01/2013
1	Interferon-gamma (Interferon, gamma)IBA 03/2012
1	CannabinoidsIBA 03/2011
1	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 03/2011
1	Amino Acids FDA Link 11/2010
1	halofuginoneIBA 11/2010
1	Phosphotransferases (Kinase)IBA 11/2010
1	Tryptophan (L-Tryptophan)FDA Link 11/2010
1	Pharmaceutical PreparationsIBA 11/2010
1	Imiquimod (Aldara)FDA LinkGeneric 04/2010
1	AntigensIBA 01/2010
1	Proteins (Proteins, Gene)FDA Link 01/2010
1	Interferon Type IIBA 01/2008
1	Double-Stranded RNA (RNA, Double Stranded)IBA 12/2006
1	Poly I-CIBA 12/2006
1	Toll-Like Receptor AgonistsIBA 12/2006
1	Myelin Basic ProteinIBA 03/2006
1	Surface Antigens (Surface Antigen)IBA 03/2006
1	Glucosamine (Dona)IBA 12/2005
1	Glucose (Dextrose)FDA LinkGeneric 12/2005
1	Proteoglycans (Proteoglycan)IBA 12/2005
1	Glycoproteins (Glycoprotein)IBA 12/2005

Therapy/Procedure

11	Therapeutics 01/2021 - 09/2007
2	Immunotherapy 03/2011 - 01/2010
1	Art Therapy 01/2018
1	Catheters 01/2014
1	Immunomodulation 10/2012